Outcomes Following Macrolide Use in Kidney Transplant Recipients.

Rachel JeongRobert R QuinnKrista L LentineAnita LloydPietro RavaniBrenda HemmelgarnBranko BraamAmit X GargKevin WenAnita Wong-ChanSita GourishankarNgan N Lam

Published in: Canadian journal of kidney health and disease (2019)

Clarithromycin and erythromycin were frequently co-prescribed in kidney transplant recipients on CNIs despite known drug interactions. Clarithromycin/erythromycin use was associated with a higher risk of hospitalization compared with azithromycin users. Safer prescribing practices in kidney transplant recipients are warranted.

Keyphrases

helicobacter pylori
primary care
helicobacter pylori infection
healthcare
adverse drug
drug induced